PHASE-I AND PHARMACOKINETIC STUDY OF 5-AZA-2'-DEOXYCYTIDINE (NSC 127716) IN CANCER-PATIENTS

被引：1
|
作者：
VANGROENINGEN, CJ
LEYVA, A
OBRIEN, AMP
GALL, HE
PINEDO, HM
机构：
来源：
CANCER RESEARCH | 1986年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4831 / 4836
页数：6
相关论文
共 50 条
  • [1] PHASE-I STUDY AND PHARMACOKINETICS OF 5-AZA-2'-DEOXYCYTIDINE (5AZACDR)
    VANGROENINGEN, CJ
    LEYVA, A
    GALL, H
    OBRIAN, A
    BOEIJE, L
    PINEDO, HM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 153 - 153
  • [2] PHASE-I STUDY ON 5-AZA-2'-DEOXYCYTIDINE IN CHILDREN WITH ACUTE-LEUKEMIA
    RIVARD, GE
    MOMPARLER, RL
    DEMERS, J
    BENOIT, P
    RAYMOND, R
    LIN, KT
    MOMPARLER, LF
    LEUKEMIA RESEARCH, 1981, 5 (06) : 453 - 462
  • [3] Phase I study of 5-aza-2′-deoxycytidine in combination with valproic acid in patients with NSCLC
    Karpenko, M. J.
    Liu, Z.
    Aimiuwu, J.
    Wang, L.
    Wu, X.
    Villalona-Calero, M. A.
    Young, D.
    Chan, K.
    Grever, M. R.
    Otterson, G. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] PHASE-I AND PHARMACOKINETIC STUDY OF BREQUINAR (DUP-785 NSC-368390) IN CANCER-PATIENTS
    DEFORNI, M
    CHABOT, GG
    ARMAND, JP
    FONTANA, X
    RECONDO, G
    DOMENGE, C
    CARDE, P
    BARBU, M
    GOUYETTE, A
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (07) : 983 - 988
  • [5] Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer
    Momparler, RL
    Bouffard, DY
    Momparler, LF
    Dionne, J
    Belanger, K
    Ayoub, J
    ANTI-CANCER DRUGS, 1997, 8 (04) : 358 - 368
  • [6] Phase I trial of continuous infusion 5-aza-2′-deoxycytidine
    Aparicio, A
    Eads, CA
    Leong, LA
    Laird, PW
    Newman, EM
    Synold, TW
    Baker, SD
    Zhao, M
    Weber, JS
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (03) : 231 - 239
  • [7] Phase I trial of continuous infusion 5-aza-2′-deoxycytidine
    A. Aparicio
    C. A. Eads
    L. A. Leong
    P. W. Laird
    E. M. Newman
    T. W. Synold
    S. D. Baker
    M. Zhao
    J. S. Weber
    Cancer Chemotherapy and Pharmacology, 2003, 51 : 231 - 239
  • [8] AN ANALYTICAL STUDY OF 5-AZA-2'-DEOXYCYTIDINE
    TOMANKOVA, H
    ZYKA, J
    PILECKOVA, Z
    MICROCHEMICAL JOURNAL, 1984, 29 (03) : 333 - 340
  • [9] 5-AZA-2'-DEOXYCYTIDINE (NSC-127716) IN NONSEMINOMATOUS TESTICULAR CANCER - PHASE-II FROM THE EORTC EARLY CLINICAL-TRIALS COOPERATIVE GROUP AND GENITOURINARY GROUP
    CLAVEL, M
    MONFARDINI, S
    FOSSA, S
    SMYTH, J
    RENARD, J
    KAYE, SB
    DROZD, A
    DODION, P
    SPLINTER, TAW
    STOTER, G
    HUININK, WWT
    ANNALS OF ONCOLOGY, 1992, 3 (05) : 399 - 400
  • [10] Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    Sanchez-Gonzalez, Blanca
    Yang, Hui
    Rosner, Gary
    Verstovsek, Srdan
    Rytting, Michael
    Wierda, William G.
    Ravandi, Farhad
    Koller, Charles
    Xiao, Lianchun
    Faderl, Stefan
    Estrov, Zeev
    Cortes, Jorge
    O'Brien, Susan
    Estey, Elihu
    Bueso-Ramos, Carlos
    Fiorentino, Jackie
    Jabbour, Elias
    Issa, Jean-Pierre
    BLOOD, 2006, 108 (10) : 3271 - 3279
12345